In a 2012 study published in the International Journal of Physiology, Pathophysiology and Pharmacology , KPV was found to suppress NF-B, which is known to induce the expression of inflammatory genes and regulate the survival, activation, and differentiation of inflammatory T cells.8 9 Having this suppressive property, KPV could be a potential treatment for serious inflammatory health conditions affecting the lungs or gastrointestinal tract, in which the NF-B pathway plays a key role.8 10 Indeed, a 2017 study in a mouse model observed that KPV administration led to significant downregulation of TNF-, a major cytokine encoded by the pro-inflammatory TNFA gene and which uses the NF-B pathway.11 12 As an antimicrobial In 2000, the Journal of Leukocyte Biology published an in vitro study describing the effect that KPV (and -MSH more broadly) could have on common pathogens
Hockel, M
Some patients continue to report fatigue, pain, cognitive symptoms, sleep disruption, and inflammatory symptoms after antibiotic treatment, often described as post-treatment Lyme disease syndrome
Weight-loss outcomes depend on starting weight, dose, adherence, diet, physical activity, medical history, and individual biology
This product must be used exclusively in regulated laboratory settings for in vitro and animal model research by qualified investigators
Gonzales, G
